Kimberly S. Taylor Sells 2,300 Shares of CME Group Inc. (CME) Stock
CME Group Inc. (NASDAQ:CME) insider Kimberly S. Taylor sold 2,300 shares of the firm’s stock in a transaction on Thursday, September 29th. The stock was sold at an average price of $106.01, for a total value of $243,823.00. Following the sale, the insider now directly owns 105,558 shares in the company, valued at approximately $11,190,203.58. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
CME Group Inc. (NASDAQ:CME) opened at 104.52 on Friday. CME Group Inc. has a 12-month low of $81.87 and a 12-month high of $110.35. The company’s 50-day moving average price is $106.83 and its 200-day moving average price is $99.14. The company has a market cap of $35.42 billion, a PE ratio of 26.39 and a beta of 0.85.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.11 by $0.03. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The business had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. During the same quarter in the previous year, the firm posted $0.95 earnings per share. CME Group’s quarterly revenue was up 10.5% on a year-over-year basis. Equities analysts anticipate that CME Group Inc. will post $4.44 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 2.30%. The ex-dividend date was Wednesday, September 7th. CME Group’s payout ratio is currently 60.61%.
A number of large investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in CME Group by 2.1% in the second quarter. Vanguard Group Inc. now owns 20,131,757 shares of the company’s stock valued at $1,960,833,000 after buying an additional 406,686 shares during the last quarter. Capital International Investors raised its stake in CME Group by 1.8% in the second quarter. Capital International Investors now owns 11,079,915 shares of the company’s stock valued at $1,079,184,000 after buying an additional 197,881 shares during the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in CME Group by 4.5% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 10,092,373 shares of the company’s stock valued at $982,997,000 after buying an additional 431,255 shares during the last quarter. BlackRock Fund Advisors raised its stake in CME Group by 6.8% in the second quarter. BlackRock Fund Advisors now owns 9,073,017 shares of the company’s stock valued at $883,712,000 after buying an additional 577,672 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in CME Group by 3.7% in the second quarter. JPMorgan Chase & Co. now owns 6,976,489 shares of the company’s stock valued at $679,507,000 after buying an additional 249,481 shares during the last quarter. 80.29% of the stock is currently owned by institutional investors and hedge funds.
CME has been the topic of several research analyst reports. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Monday, June 20th. Credit Agricole SA dropped their price objective on CME Group from $100.00 to $95.00 and set an “underperform” rating on the stock in a research note on Thursday, July 14th. Barclays PLC dropped their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a research note on Friday, July 29th. Deutsche Bank AG raised their price objective on CME Group from $110.00 to $111.00 and gave the stock a “buy” rating in a research note on Friday, July 29th. Finally, Keefe, Bruyette & Woods raised their price objective on CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a research note on Friday, July 29th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $102.89.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.